Changes in serum obestatin, preptin and ghrelins in patients with Gestational Diabetes Mellitus

dc.contributor.authorBaykus, Yakup
dc.contributor.authorGurates, Bilgin
dc.contributor.authorAydin, Suleyman
dc.contributor.authorCelik, Husnu
dc.contributor.authorKavak, Burcin
dc.contributor.authorAksoy, Aziz
dc.contributor.authorMinareci, Yagmur
dc.date.accessioned2026-08-12T17:31:30Z
dc.date.issued2012
dc.departmentFırat Üniversitesi
dc.description.abstractObjectives: The present study aims to establish the levels of acylated ghrelin, desacylated ghrelin, obestatin and preptin, during pregnancy and the postpartum period in pregnant women with Gestational Diabetes Mellitus (GDM) and healthy pregnancy women. Design and methods: The study registered 20 pregnant women with GDM and 20 healthy pregnant women. Fasting venous blood samples were collected from all cases between weeks 24 and 28 of pregnancy and after 24 h postpartum. Hormones were analyzed using ELISA method. Results: Serum acylated ghrelin (p:0.001), desacylated ghrelin (p:0.001), obestatin (p:0.006) and preptin (p:0.001) levels were all found statistically higher in both groups during the postpartum period, when compared to the pregnancy period. A positive correlation was established between desacylated ghrelin and acylated ghrelin (p:0.008), desacylated ghrelin and preptin (p:0.012) and preptin and insulin (p:0.039) in the GDM group during pregnancy. Conclusions: The studied hormones (especially desacylated ghrelin and obestatin) are critical in GDM pathophysiology based on the comparison of measure after and before the delivery. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
dc.description.sponsorshipFUBAP [1819]
dc.description.sponsorshipThe authors would like to extend their thanks to FUBAP (project no: 1819) for their financial support.
dc.identifier.doi10.1016/j.clinbiochem.2011.08.1131
dc.identifier.endpage202
dc.identifier.issn0009-9120
dc.identifier.issn1873-2933
dc.identifier.issue3
dc.identifier.pmid21889930
dc.identifier.scopus2-s2.0-84856456746
dc.identifier.scopusqualityQ2
dc.identifier.startpage198
dc.identifier.urihttps://doi.org/10.1016/j.clinbiochem.2011.08.1131
dc.identifier.urihttps://hdl.handle.net/11508/56284
dc.identifier.volume45
dc.identifier.wosWOS:000300120100004
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherPergamon-Elsevier Science Ltd
dc.relation.ispartofClinical Biochemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectGestational Diabetes Mellitus
dc.subjectObestatin
dc.subjectPreptin
dc.subjectGhrelin
dc.titleChanges in serum obestatin, preptin and ghrelins in patients with Gestational Diabetes Mellitus
dc.typeArticle

Dosyalar